|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alexander DD, Mink PJ, Adami HO, Cole P,
Mandel JS, Oken MM and Trichopoulos D: Multiple myeloma: A review
of the epidemiologic literature. Int J Cancer. 12 Suppl
120:S40–S61. 2007. View Article : Google Scholar
|
|
3
|
Hideshima T, Richardson PG and Anderson
KC: Mechanism of action of proteasome inhibitors and deacetylase
inhibitors and the biological basis of synergy in multiple myeloma.
Mol Cancer Ther. 10:2034–2042. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kornienko AE, Guenzl PM, Barlow DP and
Pauler FM: Gene regulation by the act of long non-coding RNA
transcription. BMC Biol. 11:592013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Geisler S and Coller J: RNA in unexpected
places: Long non-coding RNA functions in diverse cellular contexts.
Nat Rev Mol Cell Biol. 14:699–712. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun T: Long noncoding RNAs act as
regulators of autophagy in cancer. Pharmacol Res. 129:151–155.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fan Q, Yang L, Zhang X, Peng X, Wei S, Su
D, Zhai Z, Hua X and Li H: The emerging role of exosome-derived
non-coding RNAs in cancer biology. Cancer Lett. 414:107–115. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu AX, Huang ZY, Zhang L and Shen J:
Potential prognostic long non-coding RNA identification and their
validation in predicting survival of patients with multiple
myeloma. Tumour Biol. 39:10104283176945632017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ronchetti D, Manzoni M, Todoerti K, Neri A
and Agnelli L: In silico characterization of miRNA and long
non-coding RNA interplay in multiple myeloma. Genes (Basel).
7:E1072016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu L, Wen J, Gu X, Wu D, Lu M and Zhao Q:
Prognostic role of long non-coding RNA LINC00152 in Chinese cancer
patients: A meta-analysis. Oncotarget. 8:93227–93235.
2017.PubMed/NCBI
|
|
13
|
Bian Z, Zhang J, Li M, Feng Y, Yao S, Song
M, Qi X, Fei B, Yin Y, Hua D and Huang Z: Long non-coding RNA
LINC00152 promotes cell proliferation, metastasis, and confers 5-FU
resistance in colorectal cancer by inhibiting miR-139-5p.
Oncogenesis. 6:3952017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang X, Yu H, Sun W, Kong J, Zhang L, Tang
J, Wang J, Xu E, Lai M and Zhang H: The long non-coding RNA CYTOR
drives colorectal cancer progression by interacting with NCL and
Sam68. Mol Cancer. 17:1102018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yue B, Liu C, Sun H, Liu M, Song C, Cui R,
Qiu S and Zhong M: A positive feed-forward loop between
LncRNA-CYTOR and Wnt/β-catenin signaling promotes metastasis of
colon cancer. Mol Ther. 26:1287–1298. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu J, Shuang Z, Zhao J, Tang H, Liu P,
Zhang L, Xie X and Xiao X: Linc00152 promotes tumorigenesis by
regulating DNMTs in triple-negative breast cancer. Biomed
Pharmacother. 97:1275–1281. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Xiang C, Wang Y, Duan Y, Liu C,
Jin Y and Zhang Y: lncRNA LINC00152 knockdown had effects to
suppress biological activity of lung cancer via EGFR/PI3K/AKT
pathway. Biomed Pharmacother. 94:644–651. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu J, Liu Y, Guo C, Zhang S, Gong Z, Tang
Y, Yang L, He Y, Lian Y, Li X, et al: Upregulated long non-coding
RNA LINC00152 expression is associated with progression and poor
prognosis of tongue squamous cell carcinoma. J Cancer. 8:523–530.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cai Q, Wang Z, Wang S, Weng M, Zhou D, Li
C, Wang J, Chen E and Quan Z: Long non-coding RNA LINC00152
promotes gallbladder cancer metastasis and epithelial-mesenchymal
transition by regulating HIF-1alpha via miR-138. Open Biol.
7:1602472017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu Y, Tan C, Weng WW, Deng Y, Zhang QY,
Yang XQ, Gan HL, Wang T, Zhang PP, Xu MD, et al: Long non-coding
RNA Linc00152 is a positive prognostic factor for and demonstrates
malignant biological behavior in clear cell renal cell carcinoma.
Am J Cancer Res. 6:285–299. 2016.PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhuang W, Ge X, Yang S, Huang M, Zhuang W,
Chen P, Zhang X, Fu J, Qu J and Li B: Upregulation of lncRNA MEG3
promotes osteogenic differentiation of mesenchymal stem cells from
multiple myeloma patients by targeting BMP4 transcription. Stem
Cells. 33:1985–1997. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun Y, Pan J, Zhang N, Wei W, Yu S and Ai
L: Knockdown of long non-coding RNA H19 inhibits multiple myeloma
cell growth via NF-κB pathway. Sci Rep. 7:180792017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gu Y, Xiao X and Yang S: LncRNA MALAT1
acts as an oncogene in multiple myeloma through sponging miR-509-5p
to modulate FOXP1 expression. Oncotarget. 8:101984–101993. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen L, Hu N, Wang C, Zhao H and Gu Y:
Long non-coding RNA CCAT1 promotes multiple myeloma progression by
acting as a molecular sponge of miR-181a-5p to modulate HOXA1
expression. Cell Cycle. 17:319–329. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ji J, Tang J, Deng L, Xie Y, Jiang R, Li G
and Sun B: LINC00152 promotes proliferation in hepatocellular
carcinoma by targeting EpCAM via the mTOR signaling pathway.
Oncotarget. 6:42813–42824. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Quan FY, Jiang J, Zhai YF, Li B, Wu XH and
Nie W: The prognostic effect of LINC00152 for cancer: A
meta-analysis. Oncotarget. 8:75427–75433. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang C, Yuan N, Wu L, Wang X, Dai J, Song
P, Li F, Xu C and Zhao X: An integrated analysis for long noncoding
RNAs and microRNAs with the mediated competing endogenous RNA
network in papillary renal cell carcinoma. Onco Targets Ther.
10:4037–4050. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xue M, Zhuo Y and Shan B: MicroRNAs, long
noncoding RNAs, and their functions in human disease. Methods Mol
Biol. 1617:1–25. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang YH, Fu J, Zhang ZJ, Ge CC and Yi Y:
LncRNA-LINC00152 down-regulated by miR-376c-3p restricts viability
and promotes apoptosis of colorectal cancer cells. Am J Transl Res.
8:5286–5297. 2016.PubMed/NCBI
|
|
31
|
Yu M, Xue Y, Zheng J, Liu X, Yu H, Liu L,
Li Z and Liu Y: Linc00152 promotes malignant progression of glioma
stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway. Mol
Cancer. 16:1102017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun K, Hu P and Xu F: LINC00152/miR-139-5p
regulates gastric cancer cell aerobic glycolysis by targeting
PRKAA1. Biomed Pharmacother. 97:1296–1302. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang G, Xiong G, Cao Z, Zheng S, You L,
Zhang T and Zhao Y: miR-497 expression, function and clinical
application in cancer. Oncotarget. 7:55900–55911. 2016.PubMed/NCBI
|
|
34
|
Yu T, Zhang X, Zhang L, Wang Y, Pan H, Xu
Z and Pang X: MicroRNA-497 suppresses cell proliferation and
induces apoptosis through targeting PBX3 in human multiple myeloma.
Am J Cancer Res. 6:2880–2889. 2016.PubMed/NCBI
|
